6-chloro-2-(1-piperazinyl)pyrazine has been researched along with sk&f 81297 in 1 studies
| Studies (6-chloro-2-(1-piperazinyl)pyrazine) | Trials (6-chloro-2-(1-piperazinyl)pyrazine) | Recent Studies (post-2010) (6-chloro-2-(1-piperazinyl)pyrazine) | Studies (sk&f 81297) | Trials (sk&f 81297) | Recent Studies (post-2010) (sk&f 81297) |
|---|---|---|---|---|---|
| 157 | 8 | 24 | 274 | 0 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, N; Goñi-Allo, B; Ramos, M | 1 |
1 other study(ies) available for 6-chloro-2-(1-piperazinyl)pyrazine and sk&f 81297
| Article | Year |
|---|---|
Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Hallucinogens; Male; Microinjections; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides | 2005 |